Omnicell Inc (OMCL)
27.13
-0.30
(-1.09%)
USD |
NASDAQ |
Apr 25, 16:00
27.14
+0.01
(+0.04%)
After-Hours: 20:00
Omnicell Revenue (TTM): 1.147B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.147B |
| September 30, 2023 | 1.186B |
| June 30, 2023 | 1.235B |
| March 31, 2023 | 1.268B |
| December 31, 2022 | 1.296B |
| September 30, 2022 | 1.309B |
| June 30, 2022 | 1.258B |
| March 31, 2022 | 1.199B |
| December 31, 2021 | 1.132B |
| September 30, 2021 | 1.070B |
| June 30, 2021 | 987.48M |
| March 31, 2021 | 914.36M |
| December 31, 2020 | 892.21M |
| September 30, 2020 | 891.30M |
| June 30, 2020 | 906.40M |
| March 31, 2020 | 924.20M |
| December 31, 2019 | 897.03M |
| September 30, 2019 | 860.48M |
| June 30, 2019 | 835.95M |
| March 31, 2019 | 807.21M |
| December 31, 2018 | 787.31M |
| September 30, 2018 | 771.93M |
| June 30, 2018 | 754.41M |
| March 31, 2018 | 746.78M |
| December 31, 2017 | 712.71M |
| Date | Value |
|---|---|
| September 30, 2017 | 691.60M |
| June 30, 2017 | 681.59M |
| March 31, 2017 | 673.46M |
| December 31, 2016 | 695.91M |
| September 30, 2016 | 650.96M |
| June 30, 2016 | 599.46M |
| March 31, 2016 | 539.34M |
| December 31, 2015 | 484.56M |
| September 30, 2015 | 475.78M |
| June 30, 2015 | 463.09M |
| March 31, 2015 | 455.36M |
| December 31, 2014 | 440.90M |
| September 30, 2014 | 425.11M |
| June 30, 2014 | 406.60M |
| March 31, 2014 | 395.24M |
| December 31, 2013 | 380.58M |
| September 30, 2013 | 365.00M |
| June 30, 2013 | 355.30M |
| March 31, 2013 | 336.99M |
| December 31, 2012 | 314.03M |
| September 30, 2012 | 286.79M |
| June 30, 2012 | 266.90M |
| March 31, 2012 | 252.52M |
| December 31, 2011 | 245.54M |
| September 30, 2011 | 239.87M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
835.95M
Minimum
Jun 2019
1.309B
Maximum
Sep 2022
1.064B
Average
1.070B
Median
Sep 2021
Revenue (TTM) Benchmarks
| Teladoc Health Inc | 2.602B |
| American Shared Hospital Services | 21.32M |
| Novo Integrated Sciences Inc | 13.66M |
| Astrana Health Inc | 1.387B |
| Cryo-Cell International Inc | 31.37M |